Sr. Director, Global Head of Health Economics & Outcomes Research (Hybrid-Acton, MA or San Diego, CA)

Insulet Corporation•Acton, MA

2d•$221,300 - $331,925•Hybrid

About The Position

The Senior Director & Global Head of Health Economics & Outcomes Research (HEOR) / Payer Evidence Generation at Insulet is a strategic leader tasked with defining and communicating the clinical, economic, and humanistic value of the Omnipod® portfolio and future innovations. Collaborating with various teams, including regional and local access, Medical Affairs, Clinical Development, commercial strategy, R&D, Digital Health, Commercial, and Government Affairs, this role is pivotal in enhancing payer value evidence and health technology assessment (HTA). Reporting to the VP of Global HEMA, the incumbent will lead a global team of experts in HEOR and real-world evidence (RWE) study design, epidemiology, biostatistics, patient-reported outcomes (PROs), and health economic modeling development and adaptation.

Requirements

Bachelor’s degree in life/health sciences or related discipline, and/or equivalent combination of education and experience.
Minimum of 15 years of hands-on leadership experience in a Health Economics and Outcomes Research (HEOR) content-developing role in the life science industry (pharma and/or medtech) or consultancy, ideally at global and/or regional level
Demonstrated understanding of the cardinal HEOR-related deliverables that are required in the different phases in the life cycle of medical technologies while exhibiting creativity and out-of-the-box thinking in the delivery of HE-related activities
Deep understanding of economic modeling and real‑world data analysis approaches & methodologies and selection criteria for real-world data sources for HEOR-focused analyses across key global markets
Proven ability to translate complex evidence into clear value narratives for executives and payers
Experience in building and leading high-performing (global) HEOR teams, driving accountability, empowerment, customer centricity and collaboration across functions and teams.
Deep understanding of HTA policies, processes and requirements for medical technology in key global markets (e.g. UK) with track record of developing HEOR evidence tailored to/applied in these processes.
Strong scientific publication record.

Nice To Haves

Past or present HEOR-content producing experience in the field of diabetes or cardiovascular diseases
Master’s Degree
PharmD industry background
Hands-on modeling experience

Responsibilities

Define and oversee the execution of Insulet’s global HEOR strategy for current, in-market and future assets across all markets.
Build and mature global HEOR capabilities that strengthen Insulet’s leadership in demonstrating the health and economic added value of diabetes innovation and connected care.
Ensure HEOR evidence is embedded early in clinical development plans and evolves through launch and lifecycle management.
Build, expand and lead/mentor a high-performing global HEOR team.
Manage budgets, vendors, and compliance with HEOR guidelines.
Lead enterprise-wide HEOR planning to support optimized, sustainable access and reimbursement/coverage decisions (including HTA reviews) of Insulet assets at value-based prices at launch & during their life cycle
Oversee the design and execution of high-quality real-world evidence programs, epidemiological studies, burden-of-disease research, indirect comparisons, and PRO strategy to further demonstrate the unmet need in current diabetes care and the comparative clinical, economic and humanistic value of Insulet's current and future assets in addressing that need across our key markets.
Oversee and drive the development and selection of economic and patient-reported outcomes (PRO) endpoints and instruments to be included in Insulet trials and Insulet-sponsored effectiveness research projects and real-world evidence (RWE) partnerships to drive differentiation and value perception.
Ensure global evidence packages for Insulet assets support the needs of the various payer archetypes and HTA bodies across each of the markets Insulet (will) operate in.
Strategically drive the early the economic value assessment and maximization for pipeline assets.
Lead/oversee (the team) developing and updating a diverse suite of insights-driven economic models for each of the current and future Insulet solutions/target indications, as part of a set of global access-supporting deliverables developed for each of these assets.
Plan and drive HEOR publication planning, submission and acceptance of publications of Insulet HEOR data, in collaboration with other stakeholders in the Insulet access community and medical affairs colleagues.
Partner with the global HEMA segment leads, US and regional access teams to embed HEOR evidence into global, regional and local pricing, reimbursement, and access strategies.
Oversee the inclusion of relevant HEOR evidence in global value dossiers, AMCP dossiers, payer decks, and HTA submissions.
Lead/drive the team of health economists supporting affiliates in adapting economic models for local HTA and reimbursement/coverage approval/payer value demonstration needs.
Build relationships with academic partners, HEOR experts, and real-world data collaborators.
Represent Insulet at conferences, expert panels, and policy forums.
Effectively communicate and explain the impact of external developments in HTA and HEOR/Payer Evidence Generation-related policies across markets on Insulet business and assess/recommend how to address these effectively.